Add up everything you take, in one set of units, against the published upper limits.
Find a product in the NIH label database, paste a Supplement Facts panel, add foods from USDA data or enter ingredients one by one. The calculator converts IU, folate, vitamin A forms and mineral salts into the amounts the reference values use, totals everything, and shows each nutrient against the U.S. and EU upper levels for your life stage.
A calculator, not advice. It adds what you list and compares the totals with published reference values. It does not check your medicines, diagnose or recommend anything. Your list stays in this browser; a label search sends only your search words to the NIH database. What it does not do
SchematicHow the calculator works, drawn by EUTECNIQ. It adds what you list; it does not check your medicines.
Calculator
Stored only in this browser · no account · no tracking
Interface translated by EUTECNIQ. Result notes, the interaction explainer, the evidence quotes and the sources stay in English, the reference version.
1 · Add what you take
Search the NIH Office of Dietary Supplements’ Dietary Supplement Label Database, a public record of what U.S. supplement labels state. Choose a label and it opens in “Read a label”, where you check each line before adding it.
Searching sends only the words you type to the NIH API (api.ods.od.nih.gov). Nothing from your list is sent. Label amounts are what the label states, not test results.
Foods and drinks from USDA FoodData Central (FNDDS 2021–2023, the database behind What We Eat in America, NHANES), with nutrient values per 100 g and standard portions. The data load from this site the first time you open this tab.
For upper levels, food counts as the NASEM rules say: retinol is preformed vitamin A; folic acid and “vitamin E, added” are fortificants; magnesium and niacin from food are not counted toward their U.S. ULs (FNDDS does not separate added niacin). FNDDS has no values for iodine, manganese, molybdenum, chromium, biotin, pantothenic acid, fluoride or boron.
Use this only when an amount is the weight of the whole compound, for example “magnesium oxide 500 mg” in an ingredient list. On a U.S. Supplement Facts panel, “Magnesium (as magnesium oxide) 400 mg” already means 400 mg of magnesium (21 CFR 101.36).
Declared caffeine, EGCG or monacolins
2 · Your list
Remove every product from this browser?
3 · Your daily totals·
EUTECNIQ Atlas · Everything I Take · printed . A list of what I take and its totals against published reference values; not medical advice.
Your totals will show here as dials and bars
Add a product on the left, or load the worked example to see how the calculator reads it.
Against the upper levels
U.S. UL (NASEM)
EU UL or safe level (EFSA, adults)
RDA or AI
Caffeine, EGCG or monacolin reference
Bar colors: your products, in the order listed
Nutrients without an upper levelShow every total as a tableYour totals, the reference values and what each upper level covers
Every total, its reference values and what each upper level covers
Nutrient
Your total a day
RDA or AI · share
U.S. UL · share
EU value · share
What the values cover
Botanicals
No upper levels exist for botanical extracts. Herb-equivalent is the starting plant weight implied by the extract ratio; it says nothing about strength or effect.
Explore
How wide is the window between enough and too much?
For each nutrient: the upper level divided by the recommended amount (the RDA, or the AI where no RDA is set). A narrow window means a few products together can pass the upper level. These are the values the calculator uses.
Window width for one life stage
Tap a nutrient to see it across every life stage.
Turn on JavaScript to draw this chart.
Upper level covers total intake* Upper level covers only part of intake (for example, supplements only), so the width is not like for like
One nutrient across life stages
RDA or AIWindow up to the upper levelUpper level
Values: U.S. Dietary Reference Intakes (NASEM), as listed under Reference values and sources. A wide window is not a reason to take more.
How interactions happen
How a botanical can change what a medicine does
Most documented botanical–drug interactions run through a few mechanisms: the enzymes that break medicines down, the transporters that carry them across the gut wall, a shared active substance, or an added effect on the same body system. The calculator does not check your medicines. This explainer shows the mechanism and the measured size of the best-documented examples, each with its source.
Show the mechanisms, with measured examplesEnzymes, transporters, shared substances and added effects; 8 botanicals and foods, with sources
Where a medicine taken by mouth can be changed on its way to the blood
Inhibition · goldenseal, grapefruit juice: less of the medicine is broken down, so more reaches the blood.
Induction · St. John’s wort (hyperforin activates PXR): more CYP3A4 is made, so less reaches the blood.
Uptake blocked · green tea (nadolol), grapefruit juice (fexofenadine): less is carried in, so less is absorbed.
Simplified schematic: the same enzymes and transporters also act in other organs, and many medicines use other enzymes (CYP2D6, CYP1A2 and others). Sources in the cards below.
Enzyme induction
St. John’s wort
Hyperforin, a constituent of St. John’s wort, binds the pregnane X receptor (PXR) with an inhibition constant of 27 nM. In human liver cells, hypericum extracts or hyperforin markedly induced CYP3A4, an enzyme involved in the oxidative metabolism of more than half of all drugs1.
FDA lists St. John’s wort as a strong CYP3A inducer, a class defined as lowering the exposure (AUC) of sensitive substrates by 80% or more, and notes that its effect varies widely and depends on the preparation2. It can weaken the effects of many medicines, including birth control pills, cyclosporine, digoxin and some HIV drugs3.
Direction: less of the medicine in the blood.
Enzyme inhibition · transporters
Goldenseal
After 14 days of goldenseal, exposure to midazolam (a CYP3A probe drug) rose from 107.9 to 175.3 ng·h/mL in 16 healthy volunteers4. In an NIH-funded study of 16 volunteers, goldenseal raised midazolam exposure by a geometric mean ratio of 1.43 and lowered metformin exposure to 0.77 of its usual value; the authors describe goldenseal as inhibiting CYP3A and CYP2D65.
NCCIH describes the metformin drop, about 25 percent, as enough to potentially hinder glucose control in people with type 2 diabetes6.
Direction: more of some medicines, less of others.
Gut-wall enzyme inhibition · transporters
Grapefruit juice
Grapefruit juice can block the action of CYP3A4 in the small intestine, so more of some drugs, such as certain statins, enters the blood and stays in the body longer. For a few drugs, such as fexofenadine, it has the opposite effect through drug transporters: less of the drug enters the blood7.
FDA lists grapefruit juice as a moderate CYP3A inhibitor (raising the exposure of sensitive substrates 2- to under 5-fold); its effect varies among brands and depends on concentration, dose and preparation2.
Direction: usually more medicine in the blood; less for a few.
Uptake transporter
Green tea
Ten healthy volunteers drank 700 mL of green tea a day for 14 days. The peak concentration and exposure of a single 30 mg dose of nadolol fell by 85.3% and 85.0%, without a change in its renal clearance, and nadolol’s effect on systolic blood pressure was significantly reduced8. In cell assays, green tea inhibited nadolol uptake by the transporter OATP1A2, which the authors suggest explains the effect in part, in the intestine8. Nadolol is also a P-glycoprotein substrate9.
NCCIH adds that green tea extract can reduce blood levels of atorvastatin and that an interaction with raloxifene has been shown10.
Direction: less of the medicine in the blood.
Same active substance
Red yeast rice
Monacolin K is structurally identical to the statin lovastatin, so red yeast rice products with significant amounts of it can have the same side effects and the same types of drug interactions as statins11. FDA lists lovastatin as a sensitive CYP3A substrate, a drug whose exposure rises 5-fold or more with strong inhibitors of that pathway2.
In 26 U.S. brands that contained monacolin K, the amount ranged from 0.09 to 5.48 mg per 1,200 mg of red yeast rice, and none stated it on the label11.
Direction: a hidden extra dose of a statin.
Added effect
Garlic
Taking garlic supplements may increase the risk of bleeding, which matters for people taking anticoagulants or aspirin and before surgery12. This is not a change in the medicine’s level but two effects on the same system adding together.
Direction: a larger combined effect.
Enzyme substrate
Caffeine
Caffeine is broken down mainly by CYP1A2: FDA lists it as a sensitive CYP1A2 substrate, and lists the antidepressant fluvoxamine as a strong CYP1A2 inhibitor2. NCCIH notes theoretical reasons to suspect that echinacea might interact with caffeine13.
Direction: an inhibitor of CYP1A2 can make caffeine last longer.
Moore LB et al. St. John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor. PNAS 2000;97:7500–7502. PubMed 10852961
FDA. Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers (content current as of May 29, 2026). fda.gov
Gurley BJ et al. Supplementation with goldenseal, but not kava kava, inhibits human CYP3A activity in vivo. Clin Pharmacol Ther 2008;83:61–69. PubMed 17495878
Nguyen JT et al. Assessing transporter-mediated natural product–drug interactions via in vitro–in vivo extrapolation: clinical evaluation with a probe cocktail. Clin Pharmacol Ther 2021;109:1342–1352. PubMed 33174626
FDA. Grapefruit juice and some drugs don’t mix (content current as of July 1, 2021). fda.gov
Misaka S et al. Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects. Clin Pharmacol Ther 2014;95:432–438. PubMed
Misaka S et al. Limited sampling strategy for predicting the area under plasma concentration–time curve of nadolol in healthy subjects. J Clin Pharmacol 2025;65:621–627. PubMed 39551720
Only a pharmacist or clinician who knows your medicines can say whether any of this applies to you. Absence from this list does not mean a botanical has no interactions.
Evidence map
What the research says about 15 popular botanicals, in NCCIH’s words
Each chip is one statement from the U.S. National Center for Complementary and Integrative Health (NCCIH) fact sheet for that botanical. EUTECNIQ sorted the statements into four groups by their wording; the quote is shown so you can judge the sorting. A group describes how strong the evidence is, not how large an effect is. Botanicals in your list are marked.
51 statements at a glance. Each block is one group; the number is how many statements fall in it. Tap a botanical to open its quotes.
Some evidence of benefit (9)Early or limited evidence (13)Unclear, mixed or too little evidence (22)Evidence of no benefit (7)
Show the 15 botanicals and NCCIH’s statementsOne chip per statement, sorted into four evidence groups
NCCIH statements on 15 botanicals, sorted by EUTECNIQ into four evidence groups
Botanical · NCCIH page updated
Some evidence of benefit
Early or limited evidence
Unclear, mixed or too little evidence
Evidence of no benefit
Turmeric, curcuminCurcuma longaApril 2025In your list
GinkgoGinkgo bilobaFebruary 2025In your list
Green teaCamellia sinensisFebruary 2025In your list
St. John’s wortHypericum perforatumMay 2025In your list
Red yeast riceMonascus purpureusNovember 2022In your list
EchinaceaEchinacea purpurea, E. angustifoliaNovember 2024In your list
AshwagandhaWithania somniferaMarch 2023In your list
GarlicAllium sativumFebruary 2025In your list
GingerZingiber officinaleFebruary 2025In your list
ValerianValeriana officinalisMay 2025In your list
Milk thistleSilybum marianumFebruary 2025In your list
Saw palmettoSerenoa repensApril 2025In your list
Black cohoshActaea racemosaNovember 2024In your list
CranberryVaccinium macrocarponNovember 2024In your list
GoldensealHydrastis canadensisFebruary 2025In your list
Choose a statement to read NCCIH’s exact words and the source.
Knee osteoarthritis, oral · Early or limited evidence: “The initial evidence is positive; higher-quality evidence is needed to reach definitive conclusions, and more research is needed to understand the impact of bioavailability on curcumin’s effects.”
Fatty liver disease (NAFLD) measures · Early or limited evidence: “Initial research suggests that oral turmeric or curcumin might improve some NAFLD measures, but it’s unclear which specific measures are consistently improved.”
Oral mucositis from cancer treatment · Early or limited evidence: “Initial research suggests that turmeric or curcumin in an oral or mouthwash formulation might improve symptoms of oral mucositis (tissue swelling and irritation in the mouth) related to cancer treatment.”
Knee osteoarthritis pain, topical · Unclear, mixed or too little evidence: “It’s unclear whether topical curcumin ointment has an effect on pain related to knee osteoarthritis.”
Safety: “Highly bioavailable formulations of curcumin, which enhance the body’s ability to absorb the curcumin, may harm your liver.”
Preventing or slowing dementia · Evidence of no benefit: “Ginkgo has not been shown to be beneficial for preventing or slowing the progression of dementia.”
Dementia symptoms · Unclear, mixed or too little evidence: “Ginkgo extract may have a modest benefit for dementia symptoms, particularly at relatively high doses, but the evidence is inconsistent.”
Cognitive performance in healthy people · Unclear, mixed or too little evidence: “Although dietary supplements containing ginkgo have been marketed for “brain health,” it’s uncertain whether they actually influence cognitive performance in healthy people.”
Anxiety, PMS, schizophrenia, vertigo · Early or limited evidence: “For various health conditions, including anxiety, PMS, schizophrenia, and vertigo, a small amount of evidence suggests a benefit from taking ginkgo orally (by mouth), but the overall evidence is not conclusive.”
Heart disease, blood pressure, tinnitus, multiple sclerosis · Evidence of no benefit: “Research suggests that ginkgo is not helpful for preventing heart disease, treating high blood pressure, or relieving symptoms of tinnitus or multiple sclerosis.”
Safety: “Fresh ginkgo seeds are toxic when consumed orally, and serious side effects have also occurred in people who consumed roasted ginkgo seeds or the crude ginkgo plant.”
Cancer risk · Unclear, mixed or too little evidence: “Many studies have looked at the relationship between green tea consumption and the risk of various types of cancer. The overall results of these studies have been inconsistent.”
Coronary heart disease · Unclear, mixed or too little evidence: “In Asian populations but not in Western populations, green tea consumption has been linked to a lower risk of coronary heart disease.”
Body weight · Some evidence of benefit: “The catechins and caffeine in green tea and its extracts may have a modest effect on body weight. However, the effects of green tea products may vary depending on the composition of the product and the individual’s level of physical activity.”
Total and LDL cholesterol · Some evidence of benefit: “Green tea reduced total cholesterol and low-density lipoprotein (LDL) cholesterol to a small extent, but it did not affect high-density lipoprotein (HDL) cholesterol or triglycerides.”
Safety: “Although uncommon, liver injury has been reported in some people who used green tea products, primarily green tea extracts in tablet or capsule form.”
Mild or moderate depression · Some evidence of benefit: “St. John’s wort appears to be more effective than a placebo (an inactive substance) and as effective as standard antidepressant medications for mild or moderate depression.”
Severe depression, or longer than 12 weeks · Unclear, mixed or too little evidence: “It’s uncertain whether this is true for severe depression or for time periods longer than 12 weeks.”
Menopausal hot flashes; somatic symptom disorder · Early or limited evidence: “Small numbers of studies suggest that St. John’s wort may be helpful for hot flashes associated with menopause and for somatic symptom disorder (a condition involving intense anxiety about physical symptoms).”
ADHD, IBS, OCD, PMS, smoking cessation, wound healing · Unclear, mixed or too little evidence: “However, only a small amount of research has been done on the use of St. John’s wort for each of these purposes, and the evidence hasn’t clearly shown it to be helpful for any of them.”
Safety: “It has been clearly shown that St. John’s wort can interact in dangerous, sometimes life-threatening ways with a variety of medicines.”
Cholesterol, products with considerable monacolin K · Some evidence of benefit: “Red yeast rice products that have considerable amounts of monacolin K may effectively lower blood cholesterol levels, blood glucose levels, and blood pressure. […] But, because of the levels of monacolin K, these products are considered by the FDA to be unapproved new drugs and are not sold legally in the United States.”
Products with little monacolin K · Unclear, mixed or too little evidence: “Other red yeast rice products may contain very little monacolin K, and it’s unknown if these products are effective in reducing cholesterol levels or improving other areas of health.”
Safety: “Some red yeast rice products contain a contaminant called citrinin, which is toxic and can damage the kidneys.”
Catching a cold · Early or limited evidence: “Taking echinacea may slightly reduce your chances of catching a cold. […] More research is needed to confirm these findings.”
Length of a cold · Unclear, mixed or too little evidence: “It’s still unclear whether echinacea can shorten the length of a cold.”
Respiratory infections in children · Unclear, mixed or too little evidence: “One recent study found that echinacea might reduce the chance of respiratory tract infection and associated complications in children, but overall, there isn’t enough evidence to support a clear connection.”
Safety: “However, some people have allergic reactions to echinacea, which may be severe.”
Insomnia and stress · Some evidence of benefit: “Research shows that some ashwagandha preparations may be effective for insomnia and stress.”
Anxiety · Unclear, mixed or too little evidence: “However, evidence is unclear about its effects on anxiety.”
Testosterone and sperm quality · Early or limited evidence: “There is some limited evidence that suggests that taking ashwagandha for 2 to 4 months may increase testosterone levels and sperm quality.”
Asthma, athletic performance, cognition, diabetes, menopause, female infertility · Unclear, mixed or too little evidence: “There isn’t enough evidence to determine if ashwagandha is helpful for any other health conditions, such as asthma, athletic performance, cognitive function, diabetes, menopause, and female infertility.”
Safety: “Although it is rare, there have been a number of cases that link liver injury to ashwagandha supplements.”
Cholesterol, in people with high levels · Some evidence of benefit: “Garlic supplements may reduce levels of total cholesterol and low-density lipoprotein (LDL) cholesterol to a small extent in people who have high blood cholesterol levels.”
Blood pressure, in people with high blood pressure · Early or limited evidence: “Limited evidence suggests that garlic supplements may reduce blood pressure to a small extent in people who have high blood pressure.”
Blood sugar, in people with diabetes · Some evidence of benefit: “Garlic supplements may reduce blood sugar to a small extent in people with diabetes.”
Stomach cancer risk · Evidence of no benefit: “Consuming garlic does not seem to reduce the risk of stomach cancer.”
Colorectal cancer risk · Unclear, mixed or too little evidence: “It’s uncertain whether garlic influences the risk of colorectal cancer.”
Immune support in cold and flu season · Unclear, mixed or too little evidence: “However, very little research has been done on this topic.”
Safety: “Taking garlic supplements may increase the risk of bleeding.”
Nausea and vomiting of pregnancy · Some evidence of benefit: “Research shows that ginger may be helpful for nausea and vomiting associated with pregnancy.”
Motion sickness · Evidence of no benefit: “Most studies of ginger for motion sickness haven’t shown it to be helpful.”
Nausea from chemotherapy or after surgery · Unclear, mixed or too little evidence: “It’s uncertain whether ginger is a helpful addition to standard treatments for nausea and vomiting associated with cancer chemotherapy and whether it’s helpful for nausea and vomiting after surgery.”
Menstrual cramps · Early or limited evidence: “Research suggests that ginger dietary supplements might be helpful for reducing the severity of menstrual cramps.”
Knee osteoarthritis, oral · Early or limited evidence: “Ginger dietary supplements might be helpful for symptoms of knee osteoarthritis, but much of the research has been of poor quality.”
Knee osteoarthritis, topical · Evidence of no benefit: “Ginger used topically (applied to the skin) has not been shown to be helpful for knee osteoarthritis symptoms.”
Sleep problems · Unclear, mixed or too little evidence: “The evidence on whether valerian is helpful for sleep problems is inconsistent. In its 2017 clinical practice guidelines, the American Academy of Sleep Medicine recommended against using valerian for chronic insomnia in adults.”
Menopause symptoms · Early or limited evidence: “Three small studies suggest that valerian might be helpful for menopause symptoms, but there is not enough evidence to know for certain.”
Anxiety, depression, PMS, menstrual cramps, stress · Unclear, mixed or too little evidence: “There’s not enough evidence to allow any conclusions about whether valerian is helpful for anxiety, depression, premenstrual syndrome, dysmenorrhea (menstrual cramps), stress, or other conditions.”
Blood sugar in type 2 diabetes · Early or limited evidence: “Results from a small number of studies in people show that milk thistle extracts may help to control blood sugar in people with type 2 diabetes. Most of this research was done in Middle Eastern countries, and it is unclear whether the same results would be seen in other parts of the world.”
Liver diseases · Unclear, mixed or too little evidence: “Results from clinical trials of milk thistle for liver diseases, such as alcohol-related liver disease, hepatitis B and C, non-alcoholic fatty liver disease, and liver problems caused by cancer chemotherapy, low oxygen levels, or toxins have been conflicting or too limited to allow conclusions to be reached.”
Breast milk production · Unclear, mixed or too little evidence: “It is unclear whether milk thistle has an effect on breast milk production.”
Enlarged prostate (BPH) symptoms · Evidence of no benefit: “A 2023 review of 27 studies on saw palmetto in men with BPH found that this herb, when administered alone, provides little or no benefit for BPH symptoms.”
Chronic prostatitis or pelvic pain · Evidence of no benefit: “A 2022 review of five studies on saw palmetto for chronic prostatitis/chronic pelvic pain syndrome did not find a significant benefit of the herb in patients with this condition.”
Male-pattern hair loss · Unclear, mixed or too little evidence: “The evidence is too limited to allow conclusions to be reached.”
Menopause symptoms, hot flashes · Some evidence of benefit: “A 2023 review of 22 studies of products containing black cohosh extracts, alone or in combination with other herbs, found that they were potentially beneficial for overall menopause symptoms. Data on specific symptoms showed improvements in hot flashes but not anxiety or depressive symptoms.”
Hot flashes from breast cancer treatment · Unclear, mixed or too little evidence: “It’s uncertain whether black cohosh can reduce hot flashes related to breast cancer treatment.”
Recurrent urinary tract infections in women · Early or limited evidence: “In general, cranberry products may decrease the overall risk of symptomatic, recurrent UTIs in women by 25 percent, and in some cases, by more than 30 percent. However, the effectiveness of cranberry is still in question because of inconsistent findings.”
Any health condition · Unclear, mixed or too little evidence: “There is not enough evidence to determine whether goldenseal is useful for any health conditions. More research would be needed before any conclusions can be reached.”
Safety: “Goldenseal may change the way your body processes many medications.”
Method: “some evidence of benefit” where NCCIH says a botanical appears effective, research shows it may help, or it reduced a measure; “early or limited” where NCCIH says initial, small or limited research suggests a benefit; “unclear, mixed or too little” where NCCIH says results are inconsistent, conflicting, uncertain or insufficient; “no benefit” where NCCIH says it has not been shown to help or was not helpful. NCCIH pages downloaded November 8, 2026; NCCIH material is in the public domain.
How it reads a label
The conversions, and where each comes from
Try a conversion. The same factors the calculator uses, with their sources.
Show the unit conversionsHow IU, DFE, RAE and mineral salts are converted, and the source for each
Unit conversions used by the calculator
On the label
Converted to
Factor
Source
Vitamin D, IU
µg
1 µg = 40 IU
NIH ODS, vitamin D fact sheet
Vitamin E, IU, natural form (d-alpha, RRR)
mg alpha-tocopherol
× 0.67
NIH ODS, vitamin E fact sheet
Vitamin E, IU, synthetic form (dl-alpha, all-rac)
mg alpha-tocopherol
× 0.45
NIH ODS, vitamin E fact sheet
Vitamin A, IU, retinol or retinyl esters
µg RAE
× 0.3
NIH ODS, vitamin A fact sheet
Vitamin A, IU, beta-carotene from supplements
µg RAE
× 0.3; not counted toward the UL
NIH ODS, vitamin A fact sheet
Folic acid or methylfolate, µg
µg DFE
× 1.7
FDA, Converting Units of Measure (2019); 1.7 is the stated maximum for synthetic folate
Mineral, “(as … )” on a U.S. Supplement Facts panel
the mineral itself
none: the label already gives the element
21 CFR 101.36(b)(2)(ii)
Mineral compound by weight
elemental mineral
atomic mass × count ÷ molar mass of the formula
IUPAC standard atomic weights; formula shown with each result
Extract, n:1 ratio
starting plant weight
extract × n
Arithmetic; a ratio is not a measure of strength
Limits
What it does not do
It does not check your medicines. No flag on this page means that a combination is safe. The interaction explainer shows documented mechanisms for a few botanicals and foods; it is not a checker. Bring the printed list to a pharmacist, who can check it against your medicines.
It counts food only if you add it, and most upper levels cover food and supplements together. USDA values are averages for each food, not your brand.
It trusts the label. Products can contain more or less than they state, or ingredients they do not state. The NIH database records what labels state, not laboratory results.
It recommends nothing. A total below an upper level is not a recommendation to take it, and the upper levels do not apply to people taking a nutrient under medical supervision. Children, pregnancy and lactation have their own values; choose the right life stage.
Upper levels are not the same everywhere. EFSA’s values for vitamin B6, vitamin E, zinc, selenium, iodine and magnesium are lower than the U.S. ones; the page shows both so the difference is visible.
The evidence map is a summary of summaries. It reflects NCCIH’s wording on the date shown, not a new review of the studies.
Method
Reference values and sources
Show the reference values and sourcesU.S. and EU upper levels and where each comes from
U.S. values
Recommended Dietary Allowances, Adequate Intakes and Tolerable Upper Intake Levels from the National Academies’ Dietary Reference Intakes summary tables (NCBI Bookshelf NBK545442), including what each UL covers: preformed vitamin A only; alpha-tocopherol, niacin and folate from supplements and fortified foods; magnesium from supplements and medicines only.
FDA, Spilling the Beans (400 mg a day for healthy adults); EFSA 2015 caffeine opinion (200 mg single doses; 400 mg a day; 200 mg a day in pregnancy and lactation; 3 mg/kg a day for children); EFSA 2018 on green tea catechins; Regulation (EU) 2022/860 on monacolins from red yeast rice; NCCIH on red yeast rice and St. John’s wort.
Product labels
NIH Office of Dietary Supplements, Dietary Supplement Label Database, through its public Label API (version 9; data CC0 1.0). Each label is converted line by line into the label reader, with its forms, so you can check every line before it is added.
Foods
U.S. Department of Agriculture, Agricultural Research Service. FoodData Central: Food and Nutrient Database for Dietary Studies (FNDDS) 2021–2023, survey foods, CSV release of October 31, 2024 (5,432 foods; public domain, CC0 1.0). Values per 100 g and FNDDS portion weights, as published.
Interactions
FDA table of substrates, inhibitors and inducers (May 29, 2026); FDA consumer update on grapefruit juice (2021); NCCIH fact sheets; and the clinical studies cited in the explainer, read in the original abstracts.
Evidence map
NCCIH fact sheets for 15 botanicals, quoted verbatim, with each page’s “last updated” date.
Languages
The interface is available in Spanish, French, Portuguese, Chinese (Simplified) and Hindi, translated by EUTECNIQ. Notes, the explainer, the quotes and the sources stay in English, the reference version.
Offline
After the first visit, the page, its data and the food table are kept by your browser so the calculator also works without a connection. The label search needs a connection.
Privacy
The list is kept in this browser’s storage under one key and in any file you save. The page sends nothing to EUTECNIQ; a label search sends only the words you type to the NIH API. Clearing the list or your browser data deletes it.
Checked
Every reference value, quote and study figure was checked against the sources above on November 8, 2026. Values change; the sources are authoritative.
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.
Ready to check what you take?
Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.